News | December 04, 2006

SCAI Abstract Deadline Extended

The Society for Cardiac Angiography and Interventions (SCAI) has extended the abstract deadline for its 30th Annual Scientific Sessions in Orlando, May 9-12, 2007. The new deadline is December 22, 2006 at midnight (EST).

The top three abstracts will received awards, and the top 10 abstracts selected will be featured for oral presentantion. All accepted abstracts will be published in the May 2007 edition of SCAI's Journal, “Catheterization and Cardiovascular Interventions.”

Abstract categories are:
-Acute Coronary Syndromes and Myocardial Infarction
-Adult Congenital
-Atherectomy/Plaque Modification
-Angiogenesis, Myogenesis, Cell Therapy and Gene Therapy
-Carotid Revascularization
-Complex PCI
-Contrast agents
-CTO
-Drug-Eluting Stents
-Endovascular & Peripheral Interventions (Excluding Neurovascular Intervention)
-Imaging: CT & MR
-Intravascular Imaging/Physiology
-Left Main & Multi-Vessel Intervention
-Interventions for Myocardial Infarction
-Miscellaneous
-Neurovascular, Carotid & Stroke Intervention
-Non-Invasive Imaging
-Pediatric
-Pharmacotherapy
-PTCA
-Restenosis
-Stents
-Thrombectomy and Distal Protection Devices
-Valvular Interventions
-Vascular Access & Arterial Closure Devices
-Vulnerable Plaque
-Women's Healthcare

For more information or to submit an abstract, visit www.scai.org.


Related Content

News | Pharmaceuticals

February 16, 2024 — AMO Pharma Limited, a privately held clinical-stage specialty biopharmaceutical company focusing on ...

Home February 16, 2024
Home
News | Pharmaceuticals

January 25, 2024 — Agepha Pharma, a leading multinational pharmaceutical company with the first FDA-approved anti ...

Home January 25, 2024
Home
News | Pharmaceuticals

November 21, 2023 — BridgeBio Pharma, Inc., a commercial-stage biopharmaceutical company focused on genetic diseases and ...

Home November 21, 2023
Home
Feature | Pharmaceuticals | By Christine Book

In a new 3-part video series on hypertrophic cardiomyopathy with Christine E. Seidman, MD, FACC, FAHA, Managing Editor ...

Home October 25, 2023
Home
Videos | Pharmaceuticals

In this third and final segment in DAIC’s “One on One” series with Dr. Christine Seidman, learn what’s on the horizon at ...

Home September 26, 2023
Home
Videos | Pharmaceuticals

In Part 2 of DAIC’s 3-part “One on One” series with Dr. Christine Seidman, a discussion on the discovery of gene-based ...

Home September 11, 2023
Home
Videos | Pharmaceuticals

A 3-part video series with Christine E. Seidman, MD, FACC, FAHA In the first of this 3-part “One on One” series, Dr ...

Home August 28, 2023
Home
News | Pharmaceuticals

August 1, 2023 —LEXEO Therapeutics, a clinical-stage gene therapy company advancing adeno-associated virus (AAV)-based ...

Home August 01, 2023
Home
News | Pharmaceuticals

July 10, 2023 — Novartis announced that the US Food and Drug Administration (FDA) has approved a label update for Leqvio ...

Home July 10, 2023
Home
Subscribe Now